ContextVision to Showcase New 3D Ultrasound Capabilities at RSNA 2015

Stockholm, Sweden – November 19, 2015 – At this year’s Scientific Assembly and Annual Meeting of RSNA, ContextVision will be demonstrating its wide range of leading 2D/3D/4D imaging enhancement software solutions for ultrasound. The company has made significant upgrades across its product range.

GOPiCE 2.0® is the second generation of ContextVision’s unique 3D/4D image enhancement software, providing OEMs with the best ultrasound image quality available. It is the only product on the market for real-time volumetric image processing for ultrasound. New to the software is the ability to optimize for different visualization techniques, both MPR and rendered view; intelligent near- and far-field processing that guarantees excellent image quality throughout the whole volume; and, by utilizing information from adjacent planes in the 3D volume, processing and delivering a clearer image than ever before.

ContextVision will also be showcasing REALiCE®, the company’s versatile visualization software incorporating GOPiCE 2.0. True-to-data rendering technology provides unique views of anatomies, including photo-like images, and supports early fetal diagnosis. With clearer imaging, standard fetus measurements become more accurate. New to REALiCE are the Skeletal View, Surface Rendering View and Depth Color Coding View. The improved Photographic View for REALiCE will also be presented at RSNA, which has proved far more accurate than the first generation of the feature.

US PLUSView™ 2.0 is ContextVision’s fifth generation 2D enhancement product and the world’s leading 2D image enhancement for the entire range of clinical applications. To strengthen the offering, the company has applied advanced temporal filtering, including motion compensation – an advancement that has resulted in the highest image quality. Also new to the US PLUSView technology is an upgraded doctors’ interface, enabling ultrasound manufacturers to adjust image quality to the customers’ preferences, or provide a user interface directly to clinicians.

“ContextVision is dedicated to ensuring the highest quality imaging for all kinds of equipment,” commented Anita Tollstadius, CEO, ContextVision. “We know that image quality continues to be of outmost importance for our customers, and ContextVision is continuing to innovate in order to enhance the clinical value of ultrasound imaging even further.

GOPView XR2Plus is the image enhancement technology that sets ContextVision as the gold standard of image enhancement for X-Ray, with sophisticated adaptive technology for noise suppression; edge/contrast enhancement; and effective dynamic latitude compression. The software also includes an exposure index which automatically monitors the digital X-Ray system to deliver accurate exposure measurements to patients. Additionally, the tuning tools incorporated into GOPView XR2 Plus allow manufacturers to maintain and improve the control of the image processing parameters for optimal customer satisfaction.

For demonstrations of ContextVision’s GOPiCE 2.0, REALiCE, US PLUSView 2.0 or GOPView XR2Plus, visit booth #6910 in North Building, Hall B at RSNA. To learn more about ContextVision’s collection of image enhancement software, visit www.contextvision.com.

About ContextVision
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform.  ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.